Lv41
620 积分 2024-01-11 加入
Oncolytic virus VG161 in refractory hepatocellular carcinoma
4小时前
待确认
Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studies
4小时前
已完结
Beyond cold to hot: oncolytic virotherapy as the next cornerstone of immuno-oncology
5小时前
已完结
A novel bivalent neoantigen vaccine based on mRNA-loaded lipid nanoparticles eradicates hepatocellular carcinoma in mice
5小时前
已完结
Radiofrequency Ablation for the Treatment of Bone Metastases: Results of the SPARTA Study
1个月前
已完结
Efficacy and Safety of Durvalumab Plus Tremelimumab in Hepatocellular Carcinoma Patients With Portal Vein Thrombosis and High Tumor Burden: A Multicenter Retrospective Analysis
4个月前
已完结
Checkpoint Inhibitors: Common Immune-Related Adverse Events and Their Management
4个月前
已完结
Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis
4个月前
已完结
Multiparametric MRI-Based Deep Learning and Radiomics for Predicting Progression-Free Survival Benefit in Patients with Hepatocellular Carcinoma Treated with Immunotherapy and Targeted Therapy Plus Transarterial Chemoembolization: A Bicentric Study
5个月前
已完结
Diagnosis and Management of Pelvic Venous Disorders in Women
8个月前
已完结
皖公网安备34019202002308
